Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02846623 |
|---|---|
| Brief Title: | Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome |
| First Submitted : | July 22, 2016 |
| First Submitted that Met QC Criteria : | July 22, 2016 |
| First Posted : | July 27, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 15, 2019 |
| Last Update Posted : | August 19, 2019 |